학술논문

발행년
-
(예 : 2010-2015)
'학술논문' 에서 검색결과 57건 | 목록 1~10
Academic Journal
Bascoul-Mollevi C; Biometrics Unit, Institut du Cancer Montpellier, Montpellier, France; Institut Desbrest d'Epidémiologie et de Santé Publique, Université de Montpellier, Inserm, Montpellier, France; French National Platform Quality of Life and Cancer, France. Electronic address: caroline.mollevi@chu-montpellier.fr.; Gourgou S; Biometrics Unit, Institut du Cancer Montpellier, Montpellier, France; French National Platform Quality of Life and Cancer, France.; Borg C; University Hospital of Besançon, CIC-BT1431, Besançon, France.; Etienne PL; CARIO, Hôpital Privé des côtes d'Armor, Plérin, France.; Rio E; Institut de Cancérologie de l'Ouest - Site René Gauducheau, Saint-Herblain, France.; Rullier E; Centre Hospitalier et Universitaire de Bordeaux, Hôpital Haut-Lévêque, Pessac, France.; Juzyna B; R&D Unicancer, Paris, France.; Castan F; Biometrics Unit, Institut du Cancer Montpellier, Montpellier, France; French National Platform Quality of Life and Cancer, France.; Conroy T; Medical Oncology Department, Institut de Cancérologie de Lorraine, Vandœuvre-lès-Nancy, France; Université de Lorraine, APEMAC, Equipe MICS, Nancy, France.
Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE
Academic Journal
Charton E; Human and Social Sciences Department, Centre Léon Bérard, Lyon, France; Methodology and Quality of Life Unit in Oncology, University Hospital of Besançon, Besançon, France; UMR1098, University Bourgogne Franche-Comté, INSERM, EFS BFC, Interactions Hôte-Greffon-Tumeur/Ingénierie Cellulaire et Génique, France. Electronic address: emilie.charton@lyon.unicancer.fr.; Falcoz A; Methodology and Quality of Life Unit in Oncology, University Hospital of Besançon, Besançon, France; UMR1098, University Bourgogne Franche-Comté, INSERM, EFS BFC, Interactions Hôte-Greffon-Tumeur/Ingénierie Cellulaire et Génique, France.; François E; IVIDATA Group, Paris, France.; Touraine C; Montpellier Cancer Institute (ICM), University of Montpellier, Montpellier, France.; Bachet JB; Department of Hepato-Gastroenterology, Groupe hospitalier Pitié Salpêtrière, Sorbonne University, UPMC University, Paris, France.; Louvet C; Department of Oncology, Institut Mutualiste Montsouris, Paris, France.; Hamidou Z; French National Platform Quality of Life and Cancer, France; EA3279 Self-perceived Health Assessment Research Unit, Aix-Marseille University, Marseille, France.; Bascoul-Mollevi C; Montpellier Cancer Institute (ICM), University of Montpellier, Montpellier, France; French National Platform Quality of Life and Cancer, France; Institute of Cancer Research of Montpellier (IRCM), ICM, INSERM, Montpellier, France.; Anota A; Human and Social Sciences Department, Centre Léon Bérard, Lyon, France; UMR1098, University Bourgogne Franche-Comté, INSERM, EFS BFC, Interactions Hôte-Greffon-Tumeur/Ingénierie Cellulaire et Génique, France; French National Platform Quality of Life and Cancer, France; Department of Clinical Research and Innovation, Centre Léon Bérard, Lyon, France.
Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8506513 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7565 (Electronic) Linking ISSN: 01692607 NLM ISO Abbreviation: Comput Methods Programs Biomed Subsets: MEDLINE
Academic Journal
Bascoul-Mollevi C; Biometrics Unit - CTD INCa, Institut du Cancer Montpellier, Univ. Montpellier, Montpellier, France. Caroline.Mollevi@icm.unicancer.fr.; Institut de Recherche en Cancérologie de Montpellier Inserm U1194, University Montpellier, 208 rue des Apothicaire, Montpellier Cedex 5, 34298, Montpellier, France. Caroline.Mollevi@icm.unicancer.fr.; National Platform Quality of Life and Cancer, Montpellier, France. Caroline.Mollevi@icm.unicancer.fr.; Barbieri A; Inserm UMR 1219, University Bordeaux, Bordeaux, France.; Bourgier C; Institut de Recherche en Cancérologie de Montpellier Inserm U1194, University Montpellier, 208 rue des Apothicaire, Montpellier Cedex 5, 34298, Montpellier, France.; Department of Radiation Oncology, Institut du Cancer Montpellier, University Montpellier, Montpellier, France.; Conroy T; Medical Oncology Department, Institut de Cancérologie de Lorraine, Vandœuvre-lès-Nancy, France.; Lorraine University, APEMAC, Team MICS, Nancy, France.; Chauffert B; Medical Oncology Department, Amiens University Hospital, Amiens, France.; Hebbar M; Department of Medical Oncology, University Hospital, Lille, France.; Jacot W; Institut de Recherche en Cancérologie de Montpellier Inserm U1194, University Montpellier, 208 rue des Apothicaire, Montpellier Cedex 5, 34298, Montpellier, France.; Department of Medical Oncology, Institut du Cancer Montpellier, University Montpellier, Montpellier, France.; Juzyna B; R&D Unicancer, Paris, France.; De Forges H; Clinical Research and Innovation Department, Institut du Cancer Montpellier, University Montpellier, Montpellier, France.; Gourgou S; Biometrics Unit - CTD INCa, Institut du Cancer Montpellier, Univ. Montpellier, Montpellier, France.; National Platform Quality of Life and Cancer, Montpellier, France.; Bonnetain F; National Platform Quality of Life and Cancer, Montpellier, France.; Methodology and Quality of Life in Oncology Unit, University Hospital of Besançon, Besançon, France.; UMR1098, Interactions Hôte-Greffon-Tumeur/Ingénierie Cellulaire Et Génique, Bourgogne Franche-Comté University, Inserm, EFS BFC, Fédération Hospitalo-Universitaire INCREASE, Besançon, France.; Touraine C; Biometrics Unit - CTD INCa, Institut du Cancer Montpellier, Univ. Montpellier, Montpellier, France.; National Platform Quality of Life and Cancer, Montpellier, France.; Anota A; National Platform Quality of Life and Cancer, Montpellier, France.; Methodology and Quality of Life in Oncology Unit, University Hospital of Besançon, Besançon, France.; UMR1098, Interactions Hôte-Greffon-Tumeur/Ingénierie Cellulaire Et Génique, Bourgogne Franche-Comté University, Inserm, EFS BFC, Fédération Hospitalo-Universitaire INCREASE, Besançon, France.
Publisher: Springer Netherlands Country of Publication: Netherlands NLM ID: 9210257 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-2649 (Electronic) Linking ISSN: 09629343 NLM ISO Abbreviation: Qual Life Res Subsets: MEDLINE
Academic Journal
Charton E; Methodology and Quality of Life Unit in Oncology (INSERM UMR 1098), University Hospital of Besançon, 3 Boulevard Fleming, 25030, Besançon, France. echarton@chu-besancon.fr.; University Bourgogne Franche-Comté, INSERM, EFS BFC, UMR1098, Interactions Hôte-Greffon-Tumeur/Ingénierie Cellulaire et Génique, Besançon, France. echarton@chu-besancon.fr.; Cuer B; Montpellier Cancer Institute (ICM), University of Montpellier, Montpellier, France.; Institute of Cancer Research of Montpellier (IRCM), ICM, INSERM, Montpellier, France.; Cottone F; Data Center and Health Outcomes Research Unit, Italian Group for Adult Hematologic Diseases (GIMEMA), Rome, Italy.; Efficace F; Data Center and Health Outcomes Research Unit, Italian Group for Adult Hematologic Diseases (GIMEMA), Rome, Italy.; Touraine C; Montpellier Cancer Institute (ICM), University of Montpellier, Montpellier, France.; Hamidou Z; EA3279 Self-perceived Health Assessment Research Unit, Aix-Marseille University, Marseille, France.; French National Platform Quality of Life and Cancer, Besançon, France.; Fiteni F; Montpellier Cancer Institute (ICM), University of Montpellier, Montpellier, France.; Department of Medical Oncology, University Hospital of Nîmes, Nîmes, France.; Bonnetain F; Methodology and Quality of Life Unit in Oncology (INSERM UMR 1098), University Hospital of Besançon, 3 Boulevard Fleming, 25030, Besançon, France.; University Bourgogne Franche-Comté, INSERM, EFS BFC, UMR1098, Interactions Hôte-Greffon-Tumeur/Ingénierie Cellulaire et Génique, Besançon, France.; French National Platform Quality of Life and Cancer, Besançon, France.; Woronoff-Lemsi MC; University Bourgogne Franche-Comté, INSERM, EFS BFC, UMR1098, Interactions Hôte-Greffon-Tumeur/Ingénierie Cellulaire et Génique, Besançon, France.; Department of Clinical Research and Innovation, University Hospital of Besançon, Besançon, France.; Bascoul-Mollevi C; Montpellier Cancer Institute (ICM), University of Montpellier, Montpellier, France.; Institute of Cancer Research of Montpellier (IRCM), ICM, INSERM, Montpellier, France.; French National Platform Quality of Life and Cancer, Besançon, France.; Anota A; Methodology and Quality of Life Unit in Oncology (INSERM UMR 1098), University Hospital of Besançon, 3 Boulevard Fleming, 25030, Besançon, France.; University Bourgogne Franche-Comté, INSERM, EFS BFC, UMR1098, Interactions Hôte-Greffon-Tumeur/Ingénierie Cellulaire et Génique, Besançon, France.; French National Platform Quality of Life and Cancer, Besançon, France.
Publisher: Springer Netherlands Country of Publication: Netherlands NLM ID: 9210257 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-2649 (Electronic) Linking ISSN: 09629343 NLM ISO Abbreviation: Qual Life Res Subsets: MEDLINE
Academic Journal
Medical Decision Making (MED DECIS MAKING), May/Jun2009; 29(3): 343-350. (8p)
검색 결과 제한하기
제한된 항목
[AR] Bascoul-Mollevi C
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어